coccygodynia. Sacrococcygeal disorders, not elsewhere classified
Conditions
Interventions
Intervention 1: in the intervention group local injection of 1cc Lidocaine and 1cc of 40 mg Methylprednisolone in the point of maximum tenderness plus teaching of pelvic floor exercises for 4 weeks an
Treatment - Other
in the intervention group local injection of 1cc Lidocaine and 1cc of 40 mg Methylprednisolone in the point of maximum tenderness plus teaching of pelvic floor exercises for 4 weeks and lifestyle modi
in the control group local injection of 1cc Lidocaine and 1cc of 40 mg Methylprednisolone in the point of maximum tenderness plus teaching of pelvic floor exercises for 4 weeks and lifestyle modificat
Sponsors
Vice chancellor for research, Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: age 18 to 65 years; VAS scale equal to or more than 4 in any position of sitting, standing or supine lying exclusion criteria: coccygeal injection or manipulation in last 2 months; history of poor control diabetes or rheumatologic diseases; any low back pain radiating to sacrococcygeal region or interfering with appropriate position during biofeedback therapy; history of any malignancy, coccyx dislocation; acute fissure; Simultaneous biofeedback therapy due to any other reason
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coccygeal pain. Timepoint: before intervention, 4 and 8 weeks after intervention. Method of measurement: Visual Analogue Scale.;Patient's quality of life. Timepoint: before intervention, 4 and 8 weeks after intervention. Method of measurement: the standard SF36 questionare. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Hosseini
Iran University of Medical Science
Outcome results
None listed